☆ 4.7 Article

Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behcet's Syndrome and Psoriatic Arthritis

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Rheumatology

Vascular Behcet syndrome: from pathogenesis to treatment

Alessandra Bettiol et al.

Summary: Behçet syndrome is a rare chronic inflammatory disease with unknown causes, commonly characterized by mucocutaneous and ocular symptoms. Vascular involvement, including both venous and arterial thrombosis, is a unique feature of this syndrome. The pathogenesis involves impaired immune-inflammatory response and neutrophil-mediated mechanisms leading to thrombogenesis. Treatment primarily focuses on immunosuppressants rather than anticoagulation.

NATURE REVIEWS RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Immunopathogenesis of Behcet's disease and treatment modalities

T. B. van der Houwen et al.

Summary: Behcet's disease is an auto-inflammatory disease characterized by recurrent painful mucocutaneous ulcerations. The pathogenesis involves genetic susceptibility, microbial triggers, and dysregulated immune responses. Treatment focuses on controlling inflammation and managing organ involvement based on individual characteristics.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

添加到收藏夹

Article Immunology

NETosis in Psoriatic Arthritis: Serum MPO-DNA Complex Level Correlates With Its Disease Activity

Borui Li et al.

Summary: This study found that NETosis plays an important role in psoriatic arthritis. The level of MPO-DNA complex in serum is associated with disease activity and may be a useful biomarker to predict therapeutic response in PsA.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases

Giulio Cavalli et al.

Summary: IL-1α is a crucial pro-inflammatory cytokine that is present in almost all cell types and plays a central role in the pathogenesis of various organ or tissue inflammatory diseases. Three biologics are available to target and inhibit IL-1α for therapeutic management of these conditions.

AUTOIMMUNITY REVIEWS (2021)

添加到收藏夹

Article Immunology

Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behcet's syndrome

Alessandra Bettiol et al.

Summary: Behcet's syndrome (BS) is a systemic vasculitis with various clinical manifestations, where neutrophil hyperactivation plays a key role in pathogenesis. NETs and intracellular ROS production were found to be significantly increased in active non-vascular BS patients. Colchicine showed potential in reducing oxidation-induced damage by counteracting neutrophils-mediated mechanisms, indicating a possible therapeutic effect in BS.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Association of Behcet disease with psoriasis and psoriatic arthritis

Hyung Jin Hahn et al.

Summary: Research indicates that individuals with Behcet disease are more likely to develop psoriasis, with higher risk seen in male BD patients and older individuals. Additionally, Behcet disease patients are also more prone to developing psoriatic arthritis.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Cell Biology

Changes in the Gut Microbiome Contribute to the Development of Behcet's Disease via Adjuvant Effects

Qingfeng Wang et al.

Summary: Behcet's disease (BD) is associated with changes in gut microbiome, which may regulate autoimmune response via effects including increased gut permeability and enhancement of innate immunity. Transplantation of BD feces to mice resulted in altered SCFA levels, damaged intestinal barrier integrity, and increased immune responses, exacerbating autoimmune conditions in experimental models.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk

Lucia Novelli et al.

Summary: PsA is a chronic inflammatory disease affecting peripheral and axial joints, with possible presence of extra-articular manifestations and comorbidities. EAMs and comorbidities in PsA share common immunopathogenic pathways linked to systemic inflammation, and despite various therapies available, comprehensive disease control remains a challenge.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Diagnosis of Behcet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses

Mina Kiafar et al.

Summary: This study aimed to describe the clinical characteristics of patients at a referral Behcet clinic, confirming that ocular and genital lesions were more prevalent in the BD group, while oral lesions, articular involvement, and gastrointestinal manifestations were similar between groups. Patients with BD were also more likely to have multi-organ involvement. The findings of this study are important for epidemiological research and for referral Behcet clinics dealing with high pretest probability patients.

BMC RHEUMATOLOGY (2021)

添加到收藏夹

Article Ophthalmology

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behcet's Disease

Claudia Fabiani et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2020)

添加到收藏夹

Article Rheumatology

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis

Marie-Astrid Boutet et al.

RHEUMATOLOGY (2020)

添加到收藏夹

Article Rheumatology

Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behcet's phenotype: a multicentre study

Filippo Fagni et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Rheumatology

Behcet: the syndrome

Alessandra Bettiol et al.

RHEUMATOLOGY (2020)

添加到收藏夹

Review Rheumatology

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Laure Gossec et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Immunology

Efficacy of the anti-IL 17 secukinumab in refractory Behcet's syndrome: A preliminary study

Gerardo Di Scala et al.

JOURNAL OF AUTOIMMUNITY (2019)

添加到收藏夹

Review Medicine, General & Internal

Phenotypes in Behcet's syndrome

Emire Seyahi

INTERNAL AND EMERGENCY MEDICINE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential

Marie-Astrid Boutet et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Review Rheumatology

The right place of interleukin-1 inhibitors in the treatment of Behcet's syndrome: a systematic review

Alessandra Bettiol et al.

RHEUMATOLOGY INTERNATIONAL (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis

Viktor Todorovic et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Immunology

Behcet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects

M. Becatti et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

添加到收藏夹

Review Cell Biology

Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development

Dawn Queen et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

添加到收藏夹

Review Immunology

Treating the Different Phenotypes of Behcet's Syndrome

Alessandra Bettiol et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Rheumatology

Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study

Claudia Fabiani et al.

CLINICAL RHEUMATOLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo

Kristina Scheibe et al.

GUT (2017)

添加到收藏夹

Article Biochemical Research Methods

Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach

Chao-Jun Hu et al.

MOLECULAR & CELLULAR PROTEOMICS (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behcet Disease

Matteo Becatti et al.

CIRCULATION (2016)

添加到收藏夹

Article Rheumatology

Efficacy and safety profile of anti-interleukin-1 treatment in Behcet's disease: a multicenter retrospective study

Giacomo Emmi et al.

CLINICAL RHEUMATOLOGY (2016)

添加到收藏夹

Article Immunology

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

Oscar Medina-Contreras et al.

JOURNAL OF IMMUNOLOGY (2016)

添加到收藏夹

Article Immunology

Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease

M. -A. Boutet et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)

添加到收藏夹

Article Cell Biology

Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner

Pilar Alvarez et al.

MEDIATORS OF INFLAMMATION (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist

Tom Macleod et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Dermatology

Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1

Katelynn A. Milora et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

添加到收藏夹

Article Rheumatology

Extra-articular manifestations in psoriatic arthritis patients

Rosario Peluso et al.

CLINICAL RHEUMATOLOGY (2015)

添加到收藏夹

Article Chemistry, Medicinal

Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569

Joel Wolf et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2014)

添加到收藏夹

Article Dermatology

The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

F. Davatchi et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)

添加到收藏夹

Article Rheumatology

The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium

Silke Frey et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

添加到收藏夹

Review Immunology

Cytokines and Behcet's Disease

Z. Y. Zhou et al.

AUTOIMMUNITY REVIEWS (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

Jennifer E. Towne et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

添加到收藏夹

Article Rheumatology

Psoriatic Arthritis sine Psoriasis

Ignazio Olivieri et al.

JOURNAL OF RHEUMATOLOGY (2009)

添加到收藏夹

Article Rheumatology

Classification criteria for psoriatic arthritis - Development of new criteria from a large international study

William Taylor et al.

ARTHRITIS AND RHEUMATISM (2006)

添加到收藏夹

Article Rheumatology

The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes

David Magne et al.

ARTHRITIS RESEARCH & THERAPY (2006)

添加到收藏夹

Article Dermatology

Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease

U Tursen et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Four new members expand the interleukin-1 superfamily

DE Smith et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.